Current Edition

4 of the Top 7 Global CROs Have Selected Veeva Vault eTMF as Their Enterprise Standard

BARCELONA, Spain — 13 February 2019 — Veeva Systems (NYSE:VEEV) today announced four of the world’s top seven largest CROs are standardizing on Veeva Vault eTMF. These leading CROs have selected Vault eTMF to improve trial efficiency, give sponsors full visibility into TMF status, and ensure their TMFs are always inspection ready.

“CROs are taking steps to modernize their clinical operations to drive more efficient trials,” said Jim Reilly, vice president of Veeva Vault Clinical. “Our goal is to make it easier for CROs to work with sponsors and sites and accelerate drug development. We’re honored to support CROs’ mission to speed study execution and get treatments to patients faster.”

CROs are adopting Vault eTMF to improve operational performance and deliver greater transparency into TMF quality. Vault eTMF manages all TMF documents and processes in one system, in real-time, as they are executed. This active TMF operating model enables CROs to maintain an always up-to-date TMF and gives sponsors greater control of standard operating procedures for TMF management